Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-04 06:05 am Purchase | 2021-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Sumitomo Mitsui Trust Group Inc. | 1,357,472 5.140% | 1,357,472 (New Position) | Filing History |
| 2022-02-03 4:41 pm Sale | 2021-12-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | BlackRock Inc. BLK | 1,759,590 6.700% | -22,365 (-1.26%) | Filing History |
| 2021-11-09 12:03 pm Sale | 2021-10-31 | 13G | ARCTURUS THERAPEUTICS HLDGS IN ARCT | ARK Investment Management LLC | 2,853,258 10.840% | -1,105,761 (-27.93%) | Filing History |
| 2021-10-26 4:44 pm Sale | 2021-10-21 | 13D | ARCTURUS THERAPEUTICS HLDGS IN ARCT | Ultragenyx Pharmaceutical Inc. RARE | 1,200,000 4.600% | -200,000 (-14.29%) | Filing History |